DL-01 (TFA)

• Description :

  DL-01 TFA is the TFA salt form of DL-01 (HY-155870) . DL-01 TFA is a drug-linker conjugates for ADC that can be used for the synthesis of ADCs[1].

• UNSPSC :

  12352203

• Target :

  Drug-Linker Conjugates for ADC

• Related Pathways :

  Antibody-drug Conjugate/ADC Related

• Field of Research :

  Cancer

• Purity :

  99.23

• Smiles :

  CS(C1=NC=C(C=N1)C#CCCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN(CCC)CCC)C(NCC(NCOCCCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)(=O)=O.OC(C(F)(F)F)=O

• Molecular Formula :

  C57H72F3N9O15S

• Molecular Weight :

  1212.29

• References & Citations :

  [1]Yonghan Hu, et al. Antibody, antibody-drug conjugate thereof and use thereof. Patent WO2023046202A1.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  -80°C, protect from light, stored under nitrogen

• Scientific Category :

  ADC Related

• Clinical Information :

  No Development Reported